FisherVista

Planet Ventures Inc. provides retail investors indirect exposure to private space and aerospace companies via a publicly traded investment vehicle, democratizing access to the growing space economy projected to surpass $1 trillion.

Forward Industries Inc. will join the Russell 2000 and 3000 indexes in June 2026, marking a milestone that underscores growing institutional acceptance of its Solana treasury strategy.

Roth Capital Partners reaffirmed its Buy rating and $14 price target for LiveOne, highlighting the company's new AT&T Connected Car partnership as a significant B2B win that could expand subscriber access and lead to upward guidance revision.

Oncotelic Therapeutics is highlighted in a BioMedWire editorial discussing the booming drug-delivery market, with its Sapu003 and Deciparticle platforms noted as nanotechnology solutions to improve existing therapies.

Critical Infrastructure Technologies Ltd. provides an update on its executed Letter of Intent with H. Cegielski – Poznan S.A. to establish a strategic partnership for the production and deployment of the Nexus 20 autonomous platform in Central and Eastern Europe, marking a key step in strengthening NATO's Eastern Flank capa...

Australia’s growing household battery capacity is revolutionizing its energy landscape, reducing reliance on imported energy and advancing the renewable transition.

Factory-built and modular housing systems are gaining traction as faster, scalable solutions to address the U.S. housing supply crisis, with companies like BOXABL pioneering foldable homes to reduce build times and improve efficiency.

Ukraine is using AI-enabled drones to enhance attacks on Russian supply networks, marking a significant evolution in warfare technology.

Spanish researchers have developed a chemically doped carbon nanotube fiber that achieves 40% of copper's conductivity, weighs one-sixth as much, and has five times the tensile strength, potentially replacing copper wiring in EVs, drones, and aircraft.

A former high-level CIA operative, David Rush, is set to appear in court on charges of stealing hundreds of gold bars worth over $40 million, with implications for the gold industry and security protocols.

Scientists have discovered that immune cells in the brain produce fibronectin, creating a scaffold that enables diffuse midline gliomas to spread, pointing to potential new treatment targets.

The FBI seized roughly $8 billion in cryptocurrency and arrested hundreds linked to large-scale online fraud networks, targeting organized crime groups like the Democratic Karen Benevolent Army (DKBA) in a coordinated international operation.

President Trump signed an executive order granting federal agencies authority to assess cybersecurity risks of advanced AI models before public release, impacting tech giants like Apple.

ESGold Corp. entered a definitive agreement with Ocean Partners UK Ltd. to sell 100% of its gold and silver dore production from the Montauban Project, securing up to C$9 million in non-dilutive working capital and marking its transition from development to near-term production.

Ladybug Resource Group Inc. highlights its proprietary AI-enhanced digital operating ecosystem, designed to tackle inefficiencies in non-standard industrial parts manufacturing and boost the global EV supply chain.

MAX Power Mining Corp. is highlighted in an editorial exploring how surging electricity demand from artificial intelligence is driving interest in alternative clean baseload energy sources like natural hydrogen.

An editorial highlights BOXABL's foldable factory-built homes and scalable manufacturing as potential solutions to housing affordability and supply challenges, alongside industry trends from major homebuilders and technology providers.

FingerMotion Inc. announced plans to partner with BlueFlare Energy Solutions to develop AI and high-performance computing infrastructure in Western Canada, using natural gas-powered facilities with co-located bitcoin mining.

Kairos Pharma announced plans to acquire worldwide rights to Phase 1-ready c-MET inhibitor CL-741, complementing its oncology pipeline, and provided updates on ENV-105 clinical trials in prostate and lung cancers, backed by over $8 million in non-dilutive funding.

BOXABL and FG Merger II Corp. have scheduled a stockholder vote for June 9, 2026, on the business combination that would take BOXABL public on Nasdaq under the ticker 'BXBL'.